Merck shares rise on FDA approval for Winrevair
Read Time:6 Second
Merck shares gained 3.8% in after-hours trading Tuesday following approval of its new drug for a potentially fatal lung disease.
Mad about your property taxes? Join the club.
‘I am finally reviewing my financial life and have clearly made many mistakes’
A sense of complacency that pervaded options markets during the first quarter is returning, as stocks have resumed their march...
Democrats and Republicans in the U.S. Senate floated a number of closely watched measures for inclusion in a key bill...
Competition in search looms, but whether it will it be a big improvement is the big question.
Under a new rule, people receiving and applying for Supplemental Security Income will now have an easier time getting benefits.